Skip to main content

iodine i 131 iopofosine

Generic: Iodine I 131 Iopofosine

iodine i 131 iopofosine: 3 clinical trials tracked.

iodine i 131 iopofosine evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about iodine i 131 iopofosine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence5 indications · 1 study sponsors
Clinical Trial Registry Records (3)

A Phase 1b, Open-Label, Study of a Novel Targeted Radiotherapy in Children, Adolescents and Young Adults With Inoperable Relapsed or Refractory High-Grade Glioma

NCT05610891Registry updated 2026-10-01·Phase 1·CLRB
Active, not recruiting

Primary endpoint: Safety Evaluation of CLR 131

Interventionalopen50 targetStarted 2023-10Completion 2027-128 sites · Canada, United StatesCellectar Biosciences, Inc.

Therapeutic Combination of CLR 131 With External Beam Radiation in Head and Neck Cancer

NCT04105543Registry updated 2025-09-02·Phase 1
Completed

Primary endpoint: Incidence of Treatment Related Adverse Events

Interventionalopen12 enrolledStarted 2019-12Completion 2024-022 sites · United StatesUniversity of Wisconsin, Madison

An Open-Label, Dose Escalation, Efficacy, and Safety Study of CLR 131 in Children, Adolescents, and Young Adults With Select Solid Tumors, Lymphoma, and Malignant Brain Tumors

NCT03478462Registry updated 2026-10-01·Phase 1·CLRB
Active, not recruiting

Primary endpoint: Number of participants with dose limiting toxicities (DLT)

Interventionalopen30 targetStarted 2019-04Completion 2027-128 sites · Australia, Canada, United StatesCellectar Biosciences, Inc.